Other MS immunopeptidome analysis of breast (28), lung (29), ovarian cancer (30), and melanoma cell lines (31) that were treated with IFNγ showed similar remodeling with a large proportion of peptides presented in only untreated or IFNγ-treated cells. The gene discussed is IFNG; the disease is ovarian carcinoma.